Semaglutide studies: 1,194 papers with results
Page 6 of 24
- Efficacy of Once-Weekly Semaglutide vs Empagliflozin Added to Metformin in Type 2 Diabetes: Patient-Level Meta-analysis.
Lingvay I · The Journal of clinical endocrinology and metabolism · 2020
Systematic review · 4 results
- Divergent effect of diabetes on fibrosis response to semaglutide and resmetirom in noncirrhotic MASH: A meta-analysis of randomized trials.
Musso G · Med (New York, N.Y.) · 2026
Systematic review · 2 results
- Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis.
Andreadis P · Diabetes, obesity & metabolism · 2018
Systematic review · 11 results
- Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials.
Moiz A · Annals of internal medicine · 2025
Systematic review · 8 results
- A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults.
McGowan B · Nature medicine · 2025
Systematic review · 13 results
- Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis.
Avgerinos I · Diabetes, obesity & metabolism · 2020
Systematic review · 15 results
- Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis.
Masson W · Frontiers in cardiovascular medicine · 2024
Systematic review · 3 results
- Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression.
Rivera FB · Diabetes, obesity & metabolism · 2024
Systematic review · 5 results
- Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials.
Gu Y · Frontiers in pharmacology · 2023
Systematic review · 16 results
- Comparative efficacy of once-weekly semaglutide and SGLT-2 inhibitors in type 2 diabetic patients inadequately controlled with metformin monotherapy: a systematic literature review and network meta-analysis.
Sharma R · Current medical research and opinion · 2018
Systematic review · 5 results
- Comparing once-weekly semaglutide to incretin-based therapies in patients with type 2 diabetes: a systematic review and meta-analysis.
Mishriky BM · Diabetes & metabolism · 2019
Systematic review · 9 results
- Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis.
Nie Y · Obesity surgery · 2025
Systematic review · 11 results
- The efficacy and safety of glucagon-like peptide-1 receptor agonists in non-diabetic adults with overweight/obesity: An umbrella review of systematic reviews and meta-analyses.
Zamanian N · European journal of pharmacology · 2025
Systematic review · 5 results
- Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis.
Kanters S · BMJ open · 2019
Systematic review · 4 results
- Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis.
Bayoumy AB · Journal of Crohn's & colitis · 2025
Systematic review · 12 results
- Comparative Effectiveness of Glucagon-like Peptide-1- Receptor Agonists in Patients With Heart Failure With Preserved or Minimally Reduced Ejection Fraction: A Comprehensive Bayesian Network Meta-Analysis and Network Meta-Regression.
Khalil I · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
Systematic review · 14 results
- Pharmacotherapeutic efficacy on noninvasive fibrosis progression in nonalcoholic fatty liver disease: a systematic review and network meta-analysis.
Kovalic AJ · European journal of gastroenterology & hepatology · 2023
Systematic review · 2 results
- Impact of semaglutide use on glycemic and metabolic profile in adults with type 1 diabetes having overweight or obesity: A systematic review and meta-analysis.
Dutta D · Medicine · 2025
Systematic review · 12 results
- Efficacy and safety of European Medicines Agency (EMA)-approved pharmacological, endoscopic, and surgical treatments in different classes of obesity: A network meta-analysis of randomised controlled trials for the development of the SIO (Società Italiana Obesità) Italian guidelines for the diagnosis and treatment of overweight and obesity.
Barazzoni R · Diabetes, obesity & metabolism · 2026
Systematic review · 8 results
- Rate and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy with Semaglutide Use for Diabetes and Weight Loss: A Systematic Review and Meta-Analysis.
Liu Z · Ophthalmology · 2026
Systematic review · 4 results
- Cardiometabolic Profiles of Oral and Subcutaneous Glucagon-Like Peptide-1 Receptor Mono-Agonists in Adults With Overweight or Obesity: A Systematic Review and Network Meta-Analysis.
Lu Y · Diabetes, obesity & metabolism · 2026
Systematic review · 11 results
- Clinical evidence of semaglutide for metabolic dysfunction-associated steatotic liver disease (MASLD): An updated meta-analysis.
Peng TR · British journal of clinical pharmacology · 2026
Systematic review · 9 results
- Efficacy of GLP-1 receptor agonists on obesity and metabolic profile in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Shirmard FO · BMC gastroenterology · 2025
Systematic review · 3 results
- Efficacy, Safety, and Future of GLP-1 Receptor Agonists: A Systematic Literature Review and Meta-Analysis.
Katz G · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2025
Systematic review · 4 results
- Comparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis of Head-to-Head Studies.
Paccola GP · Clinical obesity · 2026
Systematic review · 13 results
- Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-Analysis.
Stogios N · JAMA psychiatry · 2026
Systematic review · 7 results
- Glucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis.
Kishi T · Translational psychiatry · 2026
Systematic review · 48 results
- Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis.
Kamrul-Hasan ABM · Endocrinology, diabetes & metabolism · 2026
Systematic review · 11 results
- Approved weight loss drugs for obesity with a thorough emphasis on GLP-1 agonist medications: A systematic review.
Gunasekaran P · Disease-a-month : DM · 2026
Systematic review · 33 results
- Comparison of pharmacotherapies for obesity with sleeve gastrectomy: a network meta-analysis and systematic review.
Omeh Z · Expert review of endocrinology & metabolism · 2026
Systematic review · 5 results
- Efficacy and safety of pharmacological and non-pharmacological interventions for antipsychotic-induced weight gain in individuals with schizophrenia: A systematic review and network meta-analysis of 55 clinical trials.
Mansour MEM · Journal of psychopharmacology (Oxford, England) · 2026
Systematic review · 1 result
- Semaglutide Beyond Diabetes and Obesity: Systematic Review and Meta-Analysis of Multisystem Therapeutic Benefits.
Eisa N · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026
Systematic review · 10 results
- Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis.
Patel T · Annals of medicine · 2023
Systematic review · 11 results
- Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH.
Majzoub AM · Alimentary pharmacology & therapeutics · 2021
Systematic review · 4 results
- Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic Review.
Meshkat S · Brain and behavior · 2025
Systematic review · 4 results
- Network Meta-Analysis: Comparison of Pharmacological Therapies in Compensated Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis for Fibrosis Regression and MASH Resolution.
Souza M · Alimentary pharmacology & therapeutics · 2026
Systematic review · 2 results
- Histological efficacy of anti-diabetic agents in MASH and the mediating role of weight loss: A network meta-analysis.
Banerjee M · Diabetes, obesity & metabolism · 2026
Systematic review · 8 results
- Efficacy and safety of novel antidiabetic drugs in patients with type 2 diabetes and chronic kidney disease: a network meta-analysis.
Zhu X · Frontiers in endocrinology · 2026
Systematic review · 1 result
- Semaglutide-Induced Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.
Khani E · Journal of clinical pharmacology · 2026
Systematic review · 3 results
- Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy: Systematic Review and Meta-Analysis.
Dhivagaran T · Neurology · 2026
Systematic review · 4 results
- Preferred Glucagon-like Peptide-1 Receptor Agonists in Adults With Type 2 Diabetes and Established Cardiovascular Disease or High Cardiovascular Risk: A Network Meta-analysis of Randomized Trials.
Abomohsen M · Canadian journal of diabetes · 2026
Systematic review · 13 results
- Evaluating the safety profile of semaglutide: an updated meta-analysis.
Rivera FB · Current medical research and opinion · 2024
Systematic review · 3 results
- Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials.
Zhang YS · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
Systematic review · 4 results
- Semaglutide reduces cardiovascular events in type 2 diabetes: a systematic review and meta-analysis highlighting enhanced benefits in chronic kidney disease.
Yao Y · European journal of medical research · 2025
Systematic review · 12 results
- Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Zhong Y · Frontiers in pharmacology · 2026
Systematic review · 3 results
- Acute pancreatitis due to different semaglutide regimens: An updated meta-analysis.
Masson W · Endocrinologia, diabetes y nutricion · 2024
Systematic review · 5 results
- Effect of semaglutide on arrhythmic, major cardiovascular, and microvascular outcomes in patients with type 2 diabetes: a systematic review and meta-analysis.
Wu R · Frontiers in endocrinology · 2025
Systematic review · 7 results
- Cardiovascular benefits of semaglutide: a systematic review and meta-analysis of randomized controlled trials.
Sadraei S · BMC cardiovascular disorders · 2025
Systematic review · 8 results
- The effect of semaglutide on blood pressure in patients with type-2 diabetes: a systematic review and meta-analysis.
Wu W · Endocrine · 2024
Systematic review · 6 results
- Semaglutide effects on safety and cardiovascular outcomes in patients with overweight or obesity: a systematic review and meta-analysis.
Cleto AS · International journal of obesity (2005) · 2025
Systematic review · 10 results